Explore evidence

8.3 %HIV prevalence among tertiary student MSM in Nairobi was 8.3%.

KenyaVIH/sidaobserved 2021published 2023AIDS research and therapyPubMeddocument of 14 observations

37.5 %37.5% of adolescent girls were unaware if their partner had ever tested for HIV.

KenyaVIH/sidapublished 2023The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument of 7 observations

15 %Pneumocystis jirovecii was present in 24 (15%) of 162 HIV-attributed infant or child deaths.

KenyaVIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations

0.8 %The percentage of HIV infections with PrEP-associated nucleoside reverse transcriptase inhibitor (NRTI) drug resistance was 0.8% in the oral HIV self-testing scenario.

KenyaVIH/sidapublished 2024The lancet. HIVPubMeddocument of 6 observations

78 %Missed opportunities in screening for PrEP eligibility were 78% for adolescent girls and young women (AGYW).

KenyaVIH/sidaobserved February 2017 to December 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 13 observations

0.8 %The proportion of infants diagnosed with HIV was 0.8% in the intervention group.

KenyaVIH/sidapublished 2021Scientific reportsPubMeddocument of 4 observations

82,000 childrenIn Kenya, of the 82,000 children living with HIV, only 59% are receiving antiretroviral therapy (ART).

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 8 observations

3.65 AORFemale participants had nearly four-fold higher odds of water insecurity (adjusted odds ratio = 3.65).

KenyaVIH/sidapublished 2026Journal of water and healtheurope_pmcdocument of 11 observations

38.9 %Among 31,346 patients initiated on antiretroviral therapy in central Kenya, 38.9% were diagnosed at WHO stage III.

KenyaVIH/sidapublished 2022BMC infectious diseasesPubMeddocument of 10 observations

96.6 %Protease (PR) and reverse transcriptase (RT) sequences of plasma viral RNA were obtained for 96.6% and 89.7%, respectively, of the 29 patients with a detectable viral load.

KenyaVIH/sidapublished 2007Journal of clinical microbiologyeurope_pmcdocument of 4 observations

59 %After 19 months of follow-up, 44 out of 75 participants living with HIV (59%) were virally suppressed at their last viral load measure.

KenyaVIH/sidapublished 2023BMC health services researchPubMeddocument of 12 observations

21.32 USD_per_person_per_monthThe average economic cost of PrEP provision was $21.32 per person per month.

KenyaVIH/sidaobserved first year of programmatic PrEP deliverypublished 2021BMC health services researchPubMeddocument of 4 observations

1.6 per_100_person_yearsMortality rate was 1.6 per 100 person-years.

KenyaVIH/sidapublished 2022International journal of environmental research and public healthPubMeddocument of 5 observations

71.2 %Among 305 inpatients, 71.2% in the Democratic Republic of Congo had viral load ≥1000 copies/mL.

KenyaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

19 %Among 423 HIV-negative Kenyan men who have sex with men and transgender women, yearly implant was preferred by 19% in pairwise comparisons.

KenyaVIH/sidapublished 2023AIDS and behaviorPubMeddocument of 9 observations

4.7 %Among women accepting HIV self-testing in the PrEP Implementation of Mothers in Antenatal Care trial in Kenya, awareness of partner HIV status increased from 4.7% to 82.0% between pregnancy and 9 months postpartum.

KenyaVIH/sidaobserved pregnancy to 9 months postpartumpublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 11 observations

22.9 %Cumulative lost to follow-up incidence among children and adolescents initiating antiretroviral therapy in central Kenya was 22.9% at 24 months.

KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

5.1 %At week 48, 5.1% of participants in the ritonavir-boosted PI group met the primary end point of plasma HIV type 1 RNA level of at least 50 copies per milliliter.

KenyaVIH/sidaobserved week 48published 2023The New England journal of medicinePubMeddocument of 8 observations

67 %Among ART-experienced persons with baseline viremia, viral suppression at year 3 was 67% in the intervention arm and 47% in the control arm.

KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 4 observations

2.08 aHRDepot medroxyprogesterone acetate (DMPA) was significantly associated with elevated risk of HIV seroconversion in women without bacterial vaginosis (adjusted hazard ratio 2.08, 95% confidence interval 1.46–2.97).

Kenyavaginose bactérienne · VIH/sidaobserved 1993 to 2017published 2019AIDS (London, England)europe_pmcdocument of 4 observationsDOI 10.1097/qad.0000000000002167

99 %For AGYW engaged in sex work, awareness of local HIV prevention programmes was associated with at least one HIV test (99%).

KenyaVIH/sidapublished 2020Sexual and reproductive health mattersPubMeddocument of 8 observations

23.2 %The prevalence of hypertension was found to be 23.2% among HIV positive adult patients at Kenyatta National Hospital HIV Care Centre.

Kenyahypertension artérielle · VIH/sidaobserved 2015published 2018AIDS careeurope_pmcdocument of 4 observations

1.84 adjusted_risk_ratioDrug resistance penalty score (DR-PS) ≥ 30 was associated with age 1–5 years (adjusted risk ratio = 1.84).

KenyaVIH/sidaobserved 2019 to 2023published 2025VirusesPubMeddocument of 8 observations

90.7 %Standard care resulted in 90.7% of persons living with HIV (PLWH) knowing their status.

KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 9 observations

96 %Among the 1178 clients reached for follow-up, 96% (1136/1178) tested HIV-negative at the pharmacy.

KenyaVIH/sidaobserved March to June 2022published 2025BMC health services researchPubMeddocument of 13 observations